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Identity 
Note: Not to be confused with the t(9;11)(q34;q23), 
involving MLL and FBP17. 
Clinics and pathology 
Disease 
De novo AML M5. 
Epidemiology 
Only one case to date, a 62-year-old male patient. 
Clinics 
The patient presented with multi-organ failure due to 
leukostasis and infection. WBC was 248 x 109/L. 
Prognosis 
Patient died within a few months after diagnosis. 
Cytogenetics 
Additional anomalies 
+8 and +13 in 40% of metaphases. 
Genes involved and Proteins 
MLL 
Location: 11q23 
DNA / RNA 





431 kDa; contains two DNA binding motifs (a AT 
hook, and Zinc fingers), a DNA methyl transferase 
motif, a bromodomain; transcriptional regulatory 
factor; nuclear localisation. 
AF9q34 
Location: 9q34, centromeric of FBP17 and ABL. 
DNA / RNA 
14 exons stretched over an area of about 84 kb, 5192 bp 
mRNA. 
Protein 
967 amino acids; contains a GAP related domain 
(GRD), an 'FLR'-motif, a Pleckstrin homology (PH) 
domain and a calcium/phospho-lipid-binding C2/CALB 
domain. 




5' MLL - 3' AF9q34. 
Fusion protein 
Description 
MLL/AF9q34 contains the AT-hook, DNA-
Methyltransferase, Zinc-Fingers domains of MLL and 
the entire GAP related domain (GRD) and the 
C2/CALB domain of AF9q34. 
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